Announcements Trials
Browse Landscape

Status

No longer available 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 744Observational 25Expanded_access 3

Sponsor

Cancer Type

Dermatologic 2CNS 1

Conditions

Melanoma 2Glioma 1Glioblastoma 1

Interventions

3-Iodobenzylguanidine 9Amifampridine 6nilotinib 5Magnetic Resonance Spectroscopy 5Cyclophosphamide 5trametinib 4pembrolizumab 4gallium 68 PSMA-11 4fludarabine 4elotuzumab 4dabrafenib 4Nivolumab 4Bortezomib 4Afatinib 4venetoclax 3regorafenib 3midostaurin 3fludarabine phosphate 3TIC10 compound 3Sunitinib 3Prednisone 3Lenalidomide 3Ipilimumab 3Everolimus 3Dexamethasone 3Crizotinib 3Capecitabine 3Axitinib 3Alpelisib 3Abiraterone Acetate 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Expanded_access × Ipilimumab × Clear all
NCT03460782 2019-11-08

An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and Gliomas

Center Trials & Treatment

No longer available
CNS

Glioblastoma, Glioma

NCT02186249 2017-02-08

CheckMate218

Bristol-Myers Squibb

No longer available
Dermatologic

Melanoma

NCT00495066 2013-06-03

Compassionate Use Trial for Unresectable Melanoma With Ipilimumab

Bristol-Myers Squibb

No longer available
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡